383 related articles for article (PubMed ID: 36064430)
1. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
2. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
3. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
[TBL] [Abstract][Full Text] [Related]
4. Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group.
Santos A; Geller M; Mezitis S; Rubenstein AE; Oliveira L; Medeiros Lima DJ; Suchmacher Neto M; Nigri R; Cunha KGS; Takirambudde S; Gonçalves Ribeiro M
Clin Pathol; 2020; 13():2632010X20928930. PubMed ID: 35156025
[TBL] [Abstract][Full Text] [Related]
5. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
6. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
[TBL] [Abstract][Full Text] [Related]
7. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
[TBL] [Abstract][Full Text] [Related]
8. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
9. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
[TBL] [Abstract][Full Text] [Related]
10. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
Attia S; Guirguis M; Le LQ; Chhabra A
Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
[TBL] [Abstract][Full Text] [Related]
11. A fortuitous discovery of a neurofibroma in a female patient with type 1 neurofibromatosis: a case report.
Harrabi F; Methnani J; Houssem A; Abdelkader M; Mehdi BL; Amine SM; Mohamed BM; Ali BA
J Int Med Res; 2022 Dec; 50(12):3000605221139716. PubMed ID: 36510447
[TBL] [Abstract][Full Text] [Related]
12. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
[TBL] [Abstract][Full Text] [Related]
14. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
Upadhyaya M; Huson SM; Davies M; Thomas N; Chuzhanova N; Giovannini S; Evans DG; Howard E; Kerr B; Griffiths S; Consoli C; Side L; Adams D; Pierpont M; Hachen R; Barnicoat A; Li H; Wallace P; Van Biervliet JP; Stevenson D; Viskochil D; Baralle D; Haan E; Riccardi V; Turnpenny P; Lazaro C; Messiaen L
Am J Hum Genet; 2007 Jan; 80(1):140-51. PubMed ID: 17160901
[TBL] [Abstract][Full Text] [Related]
15. Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid.
Stallworth JY; Smith LD; Vagefi MR; Pekmezci M
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e104-e106. PubMed ID: 35797671
[TBL] [Abstract][Full Text] [Related]
16. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years.
Marocchio LS; Oliveira DT; Pereira MC; Soares CT; Fleury RN
Clin Oral Investig; 2007 Jun; 11(2):165-9. PubMed ID: 17285268
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract][Full Text] [Related]
19. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
Rice FL; Houk G; Wymer JP; Gosline SJC; Guinney J; Wu J; Ratner N; Jankowski MP; La Rosa S; Dockum M; Storey JR; Carroll SL; Albrecht PJ; Riccardi VM
PLoS One; 2019; 14(5):e0216527. PubMed ID: 31107888
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]